The Evi1, microRNA-143, K-Ras axis in colon cancer
- 26 January 2011
- journal article
- Published by Wiley in FEBS Letters
- Vol. 585 (4) , 693-699
Abstract
MicroRNA profiling of diseased/non-diseased tissue has identified expression signatures associated with a wide range of pathogenic conditions including malignancy. For example, colon cancer is associated with the under expression of miRNA-143 yet the molecular etiology of under expression is unknown. The K-Ras oncogene is a target of miRNA-143. Here, we show that the ecotropic viral integration site 1 oncoprotein (Evi1) is a transcriptional suppressor of the miRNA-143 gene. We find an indirect relationship between miRNA-143 and Evi1 expression. A complex molecular axis linking Evi1, miRNA-143 is operational in human colon cancer.Keywords
Funding Information
- Lifespan/Tufts/Brown CFAR’s Retrovirology Services Laboratory (NIHP30AI042853)
- Center for Cancer Research Development (NIHP20RR017695)
- Center for Stem Cell Biology (P20RR018757)
- National Institutes of Health (T32DA013911)
This publication has 20 references indexed in Scilit:
- Decreased Expression of MicroRNA-143 and -145 in Human Gastric CancersOncology, 2009
- MicroRNA-125b is a novel negative regulator of p53Genes & Development, 2009
- Role of miR-143 targeting KRAS in colorectal tumorigenesisOncogene, 2009
- MicroRNAs as Potential Agents to Alter Resistance to Cytotoxic Anticancer TherapyCancer Research, 2007
- Genomic analysis of human microRNA transcriptsProceedings of the National Academy of Sciences, 2007
- MicroRNA Signatures in Human Ovarian CancerCancer Research, 2007
- The oncogene and developmental regulator EVI1: Expression, biochemical properties, and biological functionsGene, 2007
- Amplification of MDS1/EVI1 and EVI1, Located in the 3q26.2 Amplicon, Is Associated with Favorable Patient Prognosis in Ovarian CancerCancer Research, 2007
- MicroRNAs 143 and 145 are possible common onco-microRNAs in human cancersOncology Reports, 2006
- Extensive post-transcriptional regulation of microRNAs and its implications for cancerGenes & Development, 2006